SpyGlass Pharma buys Santen unit Advanced Vision Science for about $13 million cash
Bitget2026/10/01 12:04- SpyGlass Pharma bought Advanced Vision Science from Santen for about USD 13 million in cash, taking 100% of the shares.
- The deal secures commercial-scale manufacturing capacity for intraocular lenses used in the Phase 3 BIM-IOL System trials.
- AVS will remain the exclusive supplier of several IOL types to Santen for commercialization in Japan.
- Ongoing licensing includes AVS’s hydrophobic acrylic lens material for Bausch + Lomb’s enVista IOL line.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Justin Sun Expects a Drop in Bitcoin — Details of the One-Hour Meeting Have Emerged
From "selling subscriptions" to "selling results": Adobe (ADBE.US) experiments with weekly billing for Acrobat, BTIG says growth sustainability remains to be verified
At the MAX conference held last week, Adobe unveiled new Agentic AI tools and previewed the upcoming local MCP (Model Context Protocol) integration. This feature will allow creators to directly access third-party agents within Photoshop, Illustrator, Premiere, and After Effects.
AI investment boom leads to job growth only at construction sites
Crypto prices
More
